MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model
about
DNA vaccines, electroporation and their applications in cancer treatmentMulti-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer.DNA vaccines 2014 meeting: Highlights and overview.PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer.
P2860
MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MC32 tumor cells acquire Ag-sp ...... of CEA in a colon cancer model
@ast
MC32 tumor cells acquire Ag-sp ...... of CEA in a colon cancer model
@en
type
label
MC32 tumor cells acquire Ag-sp ...... of CEA in a colon cancer model
@ast
MC32 tumor cells acquire Ag-sp ...... of CEA in a colon cancer model
@en
prefLabel
MC32 tumor cells acquire Ag-sp ...... of CEA in a colon cancer model
@ast
MC32 tumor cells acquire Ag-sp ...... of CEA in a colon cancer model
@en
P2860
P1476
MC32 tumor cells acquire Ag-sp ...... of CEA in a colon cancer model
@en
P2093
Jeong-Im Sin
Sang-Yeul Lee
P2860
P304
P356
10.1080/21645515.2015.1016669
P577
2015-04-22T00:00:00Z